{
    "clinical_study": {
        "@rank": "52149", 
        "brief_summary": {
            "textblock": "The purpose of this study is to assess the abuse liability and examine the reinforcing\n      effects of intravenous buprenorphine and buprenorphine/naloxone combinations in healthy,\n      non-drug dependent volunteers."
        }, 
        "brief_title": "Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6", 
        "completion_date": {
            "#text": "December 2002", 
            "@type": "Actual"
        }, 
        "condition": [
            "Heroin Dependence", 
            "Opioid-Related Disorders"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Heroin Dependence", 
                "Opioid-Related Disorders"
            ]
        }, 
        "detailed_description": {
            "textblock": "not available at this time"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Individuals must be healthy, non-drug dependent volunteers, be at least 18 years of age,\n        and have no prior history of drug or alcohol abuse or dependence. Subjects must have had\n        some minimal experience with opioids (e.g. at least two prior exposures)\n\n        Exclusion Criteria:\n\n        Individuals with evidence of an active Diagnostic and Statistical Manual of Mental\n        Disorders (DSM-IV) Axis I psychiatric disorder (e.g. psychosis, manic-depressive illness,\n        organic psychiatric disorders), significant medical illness (e.g., liver or cardiovascular\n        disease) or pregnant female subjects are excluded from study participation."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": "0", 
        "firstreceived_date": "September 20, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00000331", 
            "org_study_id": "NIDA-11160-6", 
            "secondary_id": [
                "R01DA011160", 
                "R01-11160-6"
            ]
        }, 
        "intervention": {
            "intervention_name": "Opioid-Related Disorders", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Buprenorphine", 
                "Analgesics, Opioid", 
                "Naloxone"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "December 17, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Denver", 
                    "country": "United States", 
                    "state": "Colorado", 
                    "zip": "80206"
                }, 
                "name": "University of Colorado Health Sciences Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3", 
        "overall_official": {
            "affiliation": "University of Colorado, Denver", 
            "last_name": "Leslie Amass, Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Terminated", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2002", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "Observed withdrawal rating"
            }, 
            {
                "measure": "Pupil diameter"
            }, 
            {
                "measure": "Drug effect characteristics"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00000331"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University of Colorado, Denver", 
        "sponsors": {
            "collaborator": {
                "agency": "National Institute on Drug Abuse (NIDA)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "University of Colorado, Denver", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2002", 
        "study_design": "Masking: Double-Blind, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }, 
    "geocoordinates": {
        "University of Colorado Health Sciences Center": "39.739 -104.985"
    }
}